share_log

Procter & Gamble | 10-Q: Q1 2025 Earnings Report

Procter & Gamble | 10-Q: Q1 2025 Earnings Report

宝洁 | 10-Q：2025财年一季报
美股SEC公告 ·  2024/10/19 04:20

Moomoo AI 已提取核心信息

Procter & Gamble reported first quarter fiscal 2025 results with net sales decreasing 1% to $21.7 billion, as 1% pricing growth was offset by unfavorable foreign exchange impacts. Operating income increased 1% to $5.8 billion while operating margin expanded 30 basis points to 26.7%. The company delivered organic sales growth of 2%, driven by 1% higher volume and 1% pricing increases.Health Care segment led growth with organic sales up 4%, while Beauty declined 5% due primarily to weakness in the SK-II brand. The company completed its planned exit from Argentina operations, recording $0.8 billion in after-tax charges, mainly from accumulated currency translation losses. Despite this, core earnings per share increased 5% to $1.93, excluding restructuring impacts.Operating cash flow was $4.3 billion with adjusted free cash flow of $3.9 billion and productivity at 82%. The company maintained its fiscal 2025 outlook for organic sales growth of 4-5% and core EPS growth of 6-9%, while expecting to return $6-7 billion to shareholders through direct share repurchases. Management cited continued focus on productivity improvements and innovation to offset ongoing market challenges.
Procter & Gamble reported first quarter fiscal 2025 results with net sales decreasing 1% to $21.7 billion, as 1% pricing growth was offset by unfavorable foreign exchange impacts. Operating income increased 1% to $5.8 billion while operating margin expanded 30 basis points to 26.7%. The company delivered organic sales growth of 2%, driven by 1% higher volume and 1% pricing increases.Health Care segment led growth with organic sales up 4%, while Beauty declined 5% due primarily to weakness in the SK-II brand. The company completed its planned exit from Argentina operations, recording $0.8 billion in after-tax charges, mainly from accumulated currency translation losses. Despite this, core earnings per share increased 5% to $1.93, excluding restructuring impacts.Operating cash flow was $4.3 billion with adjusted free cash flow of $3.9 billion and productivity at 82%. The company maintained its fiscal 2025 outlook for organic sales growth of 4-5% and core EPS growth of 6-9%, while expecting to return $6-7 billion to shareholders through direct share repurchases. Management cited continued focus on productivity improvements and innovation to offset ongoing market challenges.
宝洁公司报告了2025财年第一季度业绩，净销售额减少1%，达到217亿，因1%的价格增长被不利的汇率期货影响抵消。营业收入增加1%，达到58亿，营业利润率扩展了30个基点，达到26.7%。公司实现了2%的有机销售增长，主要得益于成交量提高1%和价格上涨1%。医疗保健部门主导了增长，有机销售额上升4%，而美妆则因Sk-II品牌的疲软下降5%。公司完成了计划中退出阿根廷业务，记录了8亿的税后费用，主要来自积累的货币折算损失。尽管如此，核心每股收益增长了5%，达到1.93，剔除重组影响。营业现金流为43亿，调整后的自由现金流为39亿，生产率为82%。公司维持了2025财年有机销售增长4-5%和核心每股收益增长6-9%的展望，同时预计通过直接回购股份向股东返还60-70亿。管理层提到将持续关注生产率的提高和创新，以抵消持续的市场挑战。
宝洁公司报告了2025财年第一季度业绩，净销售额减少1%，达到217亿，因1%的价格增长被不利的汇率期货影响抵消。营业收入增加1%，达到58亿，营业利润率扩展了30个基点，达到26.7%。公司实现了2%的有机销售增长，主要得益于成交量提高1%和价格上涨1%。医疗保健部门主导了增长，有机销售额上升4%，而美妆则因Sk-II品牌的疲软下降5%。公司完成了计划中退出阿根廷业务，记录了8亿的税后费用，主要来自积累的货币折算损失。尽管如此，核心每股收益增长了5%，达到1.93，剔除重组影响。营业现金流为43亿，调整后的自由现金流为39亿，生产率为82%。公司维持了2025财年有机销售增长4-5%和核心每股收益增长6-9%的展望，同时预计通过直接回购股份向股东返还60-70亿。管理层提到将持续关注生产率的提高和创新，以抵消持续的市场挑战。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

独立文件8  查看翻译

独立文件9  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    如新集团
    NUS
    -- 7.560
    雷特控股
    RAY
    -- 1.240
    守护者联盟
    UG
    -- 10.880
    逸仙电商
    YSG
    -- 3.4700
    European Wax Center
    EWCZ
    -- 7.350
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    多家机构看多！中国资产将全面重估：你会如何布局？
    近期，Goldman Sachs、Morgan Stanley、Appaloosa LP等多家机构唱好中国资产。 🎙️讨论： 1. Deepseek引爆中国资产上涨，后市你怎么看？ 2. 多家中国企业1月表现提升，你更看好谁？ 展开
    中国的资产重估引发了讨论：mooer们在买什么？